Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Y... | RTCL.TV
Channel: Medicine RTCL TV
Date: 17/08/2023

### Keywords ###
#psoriasis #risankizumab #antiIL23 #biologics #RTCLTV #shorts

### Article Attribution ###
Title: Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
Authors: Matteo Megna, Angelo Ruggiero, Teresa Battista, Laura Marano, Sara Cacciapuoti ,and Luca Potestio
Publisher: MDPI AG
DOI: 10.3390/jcm12093233
DOAJ URL: https://doaj.org/article/2af544c14e10431299ff2a0900fa8971
Source URL: https://www.mdpi.com/2077-0383/12/9/3233



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:33 - Title 
0:00:39 - End